Full-Time

Senior Engineer

Risk Management

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Medical technology for diagnostics and care

Healthcare

Compensation Overview

$99k - $163.3kAnnually

Senior

San Diego, CA, USA

Minimum of 4 days in-office presence required per week.

Category
Manufacturing Engineering
Mechanical Engineering
Required Skills
Minitab
Python
MATLAB
Risk Management

You match the following Becton Dickinson's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Experience leading remediation efforts is a plus.
  • Familiarity with risk management activities that support BD's compliance with various international regulatory bodies, including ISO 14971 and ISO 13485. IEC 60601 and IEC 62304 experience a plus.
  • Experience in medical device and/or regulated industry (required).
  • Strong communication skills to relay department and area issues, ensuring clarity and cooperation across BD’s global functional teams.
  • Experience with Matlab, Python, JMP/Minitab a plus.
  • Bachelor of Science degree in engineering (Mechanical, Electrical, Materials, Biomedical, or related discipline), with a master’s degree preferred.
  • Minimum 5 years in a regulated industry, particularly within the medical device, bio-pharmaceutical, or biotechnology sectors, with a strong preference for experience at BD or similar organizations.
  • Minimum 5 years years leading and applying risk management concepts specifically within the context of medical devices ensuring high standards of patient and customer safety.
Responsibilities
  • Lead remediation efforts for updating risk management documents.
  • Lead cross functional discussions such as with engineering, design, commercial, and product teams to ensure that all hazards associated with products are identified, risks are estimated, evaluated, controlled, and documented. Monitor that risk controls are implemented, verified, and validated for products in development and verify the effectiveness of risk control measures throughout the product life cycle.
  • Develop, maintain and implement risk management plans that support product development and ongoing sustaining activities in accordance with BD’s risk management framework.
  • Lead periodic reviews of the risk management process and quality system deliverables to ensure ongoing effectiveness and document decisions and actions taken, aligned with BD’s quality systems and ensuring compliance with regulatory standards and practices.
  • Evaluate estimated risk and acceptability for each risk based on analysis outcomes, utilizing BD’s risk acceptance criteria. If risks are not acceptable, lead efforts to identify and document risk control methods.
  • Support the Benefit-Risk Analysis process and lead the evaluation of overall residual risk, ensuring alignment with BD’s strategic objectives.
  • Perform and document Risk Reviews to communicate results of the risk management process to cross-functional teams.
  • Ensure harmonization of risk management strategies across projects and their lifecycle by communicating with other Risk team members.
  • Identify opportunities for continuous improvement of the Risk Management Process.
Desired Qualifications
  • Experience leading remediation efforts is a plus.
  • Familiarity with risk management activities that support BD's compliance with various international regulatory bodies, including ISO 14971 and ISO 13485. IEC 60601 and IEC 62304 experience a plus.
  • Experience with Matlab, Python, JMP/Minitab a plus.

Becton Dickinson (BD) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on solutions for medication management and delivery; BD Life Sciences, which offers products for the safe collection and transport of diagnostic specimens; and BD Interventional, which provides devices for minimally invasive surgeries. BD generates revenue by selling medical devices, laboratory equipment, and diagnostic products. The company stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare environments.

Company Size

10,001+

Company Stage

IPO

Total Funding

$449.4K

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...